NovaBridge Biosciences NBP
NASDAQ NBP
$0.86 +0.00 (+0.10%)
At close: Nov 11, 2026 · 4:00 PM EST

NovaBridge Biosciences (NBP) Current Leases (2023 - 2025)

Updated

NovaBridge Biosciences (NBP) recorded Current Leases of $853,000 in Q2 2025.

Analysis

NovaBridge Biosciences (NBP) Current Leases (2023 - 2025) Analysis & Trends

At the end of FY2024, NovaBridge Biosciences reported Current Leases of $816,000, down 73.6% from FY2023.

  • Across earlier years, Current Leases came in at $3.09 million in FY2023.
  • The Q2 2025 figure is the highest quarterly Current Leases since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 NovaBridge Biosciences 99.23 Mn -696.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 853,000.00
Dec 31, 2024 816,000.00
Dec 31, 2023 3.09 Mn
API Access

NovaBridge Biosciences Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=NBP&period=max&api_key=YOUR_API_KEY